Plasma samples from 6 independent COVID-19 convalescent patients, with different titres of anti-Spike antibodies (Supplementary Figure 1), were used as sources of anti-SARS-CoV-2 antibodies. This evidence concerns the gene CHMP5 and COVID-19.